Autosomal Dominant Hypoparathyroidism with Severe Hypomagnesemia and Hypocalcemia, Successfully Treated with Recombinant PTH and Continuous Subcutaneous Magnesium Infusion

Articles in the same Issue

1. TABLE OF CONTENTS
2. EDITORIAL
3. Insulin-like Growth Factor-I (rhIGF-I) Therapy of Short Stature
4. Hypertrophic Cardiomyopathy with Leprechaunism
5. Endothelial Dysfunction in Growth Hormone Deficiency
6. Growth Hormone (GH) Treatment Does Not Restore Endothelial Function in Children with GH Deficiency
7. Changes in Insulin Sensitivity and Glucose Metabolism During Therapy with Recombinant Human Growth Hormone in Short Children Born Small For Gestational Age show a Negative Correlation with Baseline Measurements
8. Use of Metformin in Obese Adolescents with Hyperinsulinemia: A 6-month, Randomized, Double-blind, Placebo-controlled Clinical Trial
9. Adherence to Guidelines for and Disparities in Diabetes Care Utilization in Medicaid Children
10. Resting Energy Expenditure in Insulin Resistance Falls with Decompensation of Insulin Secretion in Obese Children
11. Insulin Receptor Autoimmunity and Insulin Resistance
12. Geographical Epidemiology of Neonatal Transitory Hypothyroidism. Trend Evidence in Central Italian Region
13. Anaphylactic Reaction to Recombinant Insulin-like Growth Factor-I
14. Autosomal Dominant Hypoparathyroidism with Severe Hypomagnesemia and Hypocalcemia, Successfully Treated with Recombinant PTH and Continuous Subcutaneous Magnesium Infusion
15. Thiamine Withdrawal Can Lead to Diabetic Ketoacidosis in Thiamine Responsive Megaloblastic Anemia: Report of Two Siblings
16. CALENDAR